Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'DIFFERENTIAL INHIBITION' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 141 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kirtikara, K; Swangkul, S; Ballou, LR
      The analysis of nonsteroidal antiinflammatory drug selectivity in prostaglandin G/H synthase (PGHS)-null cells

      INFLAMMATION RESEARCH
    2. Schmidt, H; Geisslinger, G
      Selective cyclooxygenase-2 inhibitor. Pharmacology and state of knowledge following commercial availability

      SCHMERZ
    3. Chang, DM; Young, TH; Hsu, CT; Kuo, SY; Hsieh, TC
      Endoscopic comparison of the gastroduodenal safety and the effects on arachidonic acid products between meloxicam and piroxicam in the treatment of osteoarthritis

      CLINICAL RHEUMATOLOGY
    4. Kaur, G; Kaur, G
      Role of cholinergic and GABAergic neurotransmission in the opioids-mediated GnRH release mechanism of EBP-primed OVX rats

      MOLECULAR AND CELLULAR BIOCHEMISTRY
    5. Dannhardt, G; Kiefer, W
      Cyclooxygenase inhibitors - current status and future prospects

      EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
    6. Salter, EA; Wierzbicki, A; Sperl, G; Thompson, WJ
      Molecular modeling study of COX-2 inhibition by diarylheterocycles and sulindac sulfide

      JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM
    7. Grancharov, K; Naydenova, Z; Lozeva, S; Golovinsky, E
      Natural and synthetic inhibitors of UDP-glucuronosyltransferase

      PHARMACOLOGY & THERAPEUTICS
    8. Sy, SKB; Tang, BK; Pastrakuljic, A; Roberts, EA; Kalow, W
      Detailed characterization of experimentally derived human hepatic CYP1A1 activity and expression using differential inhibition of ethoxyresorufin O-deethylation by fluvoxamine

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    9. Riendeau, D; Percival, MD; Brideau, C; Charleson, S; Dube, D; Ethier, D; Falgueyret, JP; Friesen, RW; Gordon, R; Greig, G; Guay, J; Mancini, J; Ouellet, M; Wong, E; Xu, L; Boyce, S; Visco, D; Girard, Y; Prasit, P; Zamboni, R; Rodger, IW; Gresser, M; Ford-Hutchinson, AW; Young, RN; Chan, CC
      Etoricoxib (MK-0663): Preclinical profile and comparison with other agentsthat selectively inhibit cyclooxygenase-2

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    10. Nugent, C; Prins, JB; Whitehead, JP; Wentworth, JM; Chatterjee, VKK; O'Rahilly, S
      Arachidonic acid stimulates glucose uptake in 3T3-L1 adipocytes by increasing GLUT1 and GLUT4 levels at the plasma membrane - Evidence for involvement of lipoxygenase metabolites and peroxisome proliferator-activated receptor gamma

      JOURNAL OF BIOLOGICAL CHEMISTRY
    11. Brown, WA; Skinner, SA; Malcontenti-Wilson, C; Vogiagis, D; O'Brien, PE
      Non-steroidal anti-inflammatory drugs with activity against either cyclooxygenase 1 or cyclooxygenase 2 inhibit colorectal cancer in a DMH rodent model by inducing apoptosis and inhibiting cell proliferation

      GUT
    12. Kobus, SM; Wong, SGW; Marks, GS
      Isolation of regioisomers of N-alkylprotoporphyrin IX from chick embryo liver after treatment with porphyrinogenic xenobiotics

      CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
    13. Park, TJ; Bae, SI; Choi, SE; Kang, BJ; Kim, KT
      Inhibition of nicotinic acetylcholine receptors and calcium channels by clozapine in bovine adrenal chromaffin cells

      BIOCHEMICAL PHARMACOLOGY
    14. Zhang, BH; Ho, V; Farrell, GC
      Specific involvement of G(alpha i2) with epidermal growth factor receptor signaling in rat hepatocytes, and the inhibitory effect of chronic ethanol

      BIOCHEMICAL PHARMACOLOGY
    15. Brideau, C; Van Staden, C; Chan, CC
      In vitro effects of cyclooxygenase inhibitors in whole blood of horses, dogs, and cats

      AMERICAN JOURNAL OF VETERINARY RESEARCH
    16. Conti, F; Spinelli, FR; Ossandon, A; Valesini, G
      Selective cyclooxygenase-2 inhibition: Biological and clinical effects

      ISRAEL MEDICAL ASSOCIATION JOURNAL
    17. Steinmeyer, J
      Pharmacological basis for the therapy of pain and inflammation with nonsteroidal anti-inflammatory drugs

      ARTHRITIS RESEARCH
    18. van Haeringen, NJ; van Sorge, AA; Van Delft, JL; Core-Bodelier, VMWC
      Flurbiprofen and enantiomers in ophthalmic solution tested as inhibitors of prostanoid synthesis in human blood

      JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
    19. Demasi, M; Caughey, GE; James, MJ; Cleland, LG
      Assay of cyclooxygenase-1 and 2 in human monocytes

      INFLAMMATION RESEARCH
    20. Pernas, M; Sanchez-Ramos, I; Sanchez-Monge, R; Lombardero, M; Arteaga, C; Castanera, P; Salcedo, G
      Der p 1 and Der f 1, the highly related and major allergens from house dust mites, are differentially affected by a plant cystatin

      CLINICAL AND EXPERIMENTAL ALLERGY
    21. van Ryn, J; Trummlitz, G; Pairet, M
      COX-2 selectivity and inflammatory processes

      CURRENT MEDICINAL CHEMISTRY
    22. Garcia-Nieto, R; Perez, C; Gago, F
      Automated docking and molecular dynamics simulations of nimesulide in the cyclooxygenase active site of human prostaglandin-endoperoxide synthase-2 (COX-2)

      JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
    23. Range, SP; Pang, L; Holland, E; Knox, AJ
      Selectivity of cyclo-oxygenase inhibitors in human pulmonary epithelial and smooth muscle cells

      EUROPEAN RESPIRATORY JOURNAL
    24. Mason, GF; Lai, JCK
      Nonlinear determination of Michaelis-Menten kinetics with model evaluationthrough estimation of uncertainties

      METABOLIC BRAIN DISEASE
    25. Larsen, PD; Zhong, S; Gebber, GL; Barman, SM
      Differential pattern of spinal sympathetic outflow in response to stimulation of the caudal medullary raphe

      AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
    26. Mizushina, Y; Miyazaki, S; Ohta, K; Hirota, M; Sakaguchi, K
      Novel anti-inflammatory compounds from Myrsine seguinii, terpeno-benzoic acids, are inhibitors of mammalian DNA polymerases

      BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
    27. Combs, CK; Johnson, DE; Karlo, JC; Cannady, SB; Landreth, GE
      Inflammatory mechanisms in Alzheimer's disease: Inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPAR gamma agonists

      JOURNAL OF NEUROSCIENCE
    28. Tavares, IA
      The effects of meloxicam, indomethacin or NS-398 on eicosanoid synthesis by fresh human gastric mucosa

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    29. Buerstatte, CR; Behar, KL; Novotny, EJ; Lai, JCK
      Brain regional development of the activity of alpha-ketoglutarate dehydrogenase complex in the rat

      DEVELOPMENTAL BRAIN RESEARCH
    30. Kataoka, H; Horie, Y; Koyama, R; Nakatsugi, S; Furukawa, M
      Interaction between NSAIDs and steroid in rat stomach - Safety of nimesulide as a preferential COX-2 inhibitor in the stomach

      DIGESTIVE DISEASES AND SCIENCES
    31. Van Hecken, A; Schwartz, JI; Depre, M; De Lepeleire, I; Dallob, A; Tanaka, W; Wynants, K; Buntinx, A; Arnout, J; Wong, PH; Ebel, DL; Gertz, BJ; De Schepper, PJ
      Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers

      JOURNAL OF CLINICAL PHARMACOLOGY
    32. Aguejouf, O; Malfatti, E; Belon, P; Doutremepuich, C
      Effects of acetyl salicylic acid therapy on an experimental thrombosis induced by laser beam

      THROMBOSIS RESEARCH
    33. D'Ambrosi, N; Cavaliere, F; Merlo, D; Milazzo, L; Mercanti, D; Volonte, C
      Antagonists of P2 receptor prevent NGF-dependent neuritogenesis in PC12 cells

      NEUROPHARMACOLOGY
    34. Miller, DK; Crooks, PA; Dwoskin, LP
      Lobeline inhibits nicotine-evoked [H-3]dopamine overflow from rat striatalslices and nicotine-evoked Rb-86(+) efflux from thalamic synaptosomes

      NEUROPHARMACOLOGY
    35. Puttfarcken, PS; Jacobs, I; Faltynek, CR
      Characterization of nicotinic acetylcholine receptor-mediated [H-3]-dopamine release from rat cortex and striatum

      NEUROPHARMACOLOGY
    36. Berg, J; Fellier, H; Christoph, T; Kremminger, P; Hartmann, M; Blaschke, H; Rovensky, F; Towart, R; Stimmeder, D
      Pharmacology of a selective cyclooxygenase-2 inhibitor, HN-56249: a novel compound exhibiting a marked preference for the human enzyme in intact cells

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    37. Mizushina, Y; Sugawara, F; Iida, A; Sakaguchi, K
      Structural homology between DNA binding sites of DNA polymerase beta and DNA topoisomerase II

      JOURNAL OF MOLECULAR BIOLOGY
    38. Tsubouchi, Y; Sano, H; Yamada, R; Hashiramoto, A; Kohno, M; Kusaka, Y; Kondo, M
      Preferential inhibition of cyclooxygenase-2 by meloxicam in human rheumatoid synoviocytes

      EUROPEAN JOURNAL OF PHARMACOLOGY
    39. Davies, NM; McLachlan, AJ
      Features and properties of nabumetone

      DRUGS
    40. Gamble, JT; Wong, SGW; Dailey, HA; Marks, GS
      Use of recombinant human ferrochelatase as a sensitive bioassay for N-alkylprotoporphyrin IX formed after interaction of porphyrinogenic xenobiotics with rat liver microsomes

      CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
    41. Cannon, GW; Caldwell, JR; Holt, P; McLean, B; Seidenberg, B; Bolognese, J; Ehrich, E; Mukhopadhyay, S; Daniels, B
      Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium - Results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip

      ARTHRITIS AND RHEUMATISM
    42. Day, R; Morrison, B; Luza, A; Castaneda, O; Strusberg, A; Nahir, M; Helgetveit, KB; Kress, B; Daniels, B; Bolognese, J; Krupa, D; Seidenberg, B; Ehrich, E
      A randomized trial of the efficacy and tolerability of the COX-2 inhibitorrofecoxib vs ibuprofen in patients with osteoarthritis

      ARCHIVES OF INTERNAL MEDICINE
    43. Jones, CJ; Budsberg, SC
      Physiologic characteristics and clinical importance of the cyclooxygenase isoforms in dogs and cats

      JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION
    44. Morrison, BW; Fricke, J; Brown, J; Yuan, WY; Kotey, P; Mehlisch, D
      The optimal analgesic dose of rofecoxib: Overview of six randomized controlled trials

      JOURNAL OF THE AMERICAN DENTAL ASSOCIATION
    45. Flower, RJ
      Non-steroidal anti-inflammatory drugs: back to the future

      RHEUMATOLOGY
    46. Ferguson, S; Hebert, RL; Laneuville, O
      NS-398 upregulates constitutive cyclooxygenase-2 expression in the M-1 cortical collecting duct cell line

      JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    47. Berg, J; Fellier, H; Christoph, T; Grarup, J; Stimmeder, D
      The analgesic NSAID lornoxicam inhibits cyclooxygenase (COX)-1/-2, inducible nitric oxide synthase (iNOS), and the formation of interleukin (IL)-6 invitro

      INFLAMMATION RESEARCH
    48. Laufer, S; Zechmeister, P; Klein, T
      Development of an in-vitro test system for the evaluation of cyclooxygenase-2 inhibitors

      INFLAMMATION RESEARCH
    49. Ehrich, EW; Schnitzer, TJ; McIlwain, H; Levy, R; Wolfe, F; Weisman, M; Zeng, Q; Morrison, B; Bolognese, J; Seidenberg, B; Gertz, BJ
      Effect of specific COX-2 inhibition in osteoarthritis of the knee: A 6 week double blind, placebo controlled pilot study of rofecoxib

      JOURNAL OF RHEUMATOLOGY
    50. McKenna, F
      COX-2: Separating myth from reality

      SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
    51. Wang, JL; Cheng, HF; Harris, RC
      Cyclooxygenase-2 inhibition decreases renin content and lowers blood pressure in a model of renovascular hypertension

      HYPERTENSION
    52. Ramsewak, RS; Nair, MG; DeWitt, DL; Mattson, WG; Zasada, J
      Phenolic glycosides from Dirca palustris

      JOURNAL OF NATURAL PRODUCTS
    53. Morrison, BW; Christensen, S; Yuan, WY; Brown, J; Amlani, S; Seidenberg, B
      Analgesic efficacy of the cyclooxygenase-2-specific inhibitor rofecoxib inpost-dental surgery pain: A randomized, controlled trial

      CLINICAL THERAPEUTICS
    54. Dammann, HG
      Preferential COX-2 inhibition: Its clinical relevance for gastrointestinalNSAID toxicity

      ZEITSCHRIFT FUR GASTROENTEROLOGIE
    55. Hinz, B; Brune, K
      Specific COX-2 inhibitors: Perspectives of a therapy with novel analgesic and antiinflammatory substances

      WIENER KLINISCHE WOCHENSCHRIFT
    56. Iso, H; Hennekens, CH; Stampfer, MJ; Rexrode, KM; Colditz, GA; Speizer, FE; Willett, WC; Manson, JE
      Prospective study of aspirin use and risk of stroke in women

      STROKE
    57. Botting, JH
      Nonsteroidal antiinflammatory agents

      DRUGS OF TODAY
    58. Emery, P
      Clinical aspects of COX-2 inhibitors

      DRUGS OF TODAY
    59. Panara, MR; Renda, G; Sciulli, MG; Santini, G; Di Giamberardino, M; Rotondo, MT; Tacconelli, S; Seta, F; Patrono, C; Patrignani, P
      Dose-dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjects

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    60. Rieke, CJ; Mulichak, AM; Garavito, RM; Smith, WL
      The role of arginine 120 of human prostaglandin endoperoxide H synthase-2 in the interaction with fatty acid substrates and inhibitors

      JOURNAL OF BIOLOGICAL CHEMISTRY
    61. Barry, OP; Kazanietz, MG; Pratico, D; FitzGerald, GA
      Arachidonic acid in platelet microparticles up-regulates cyclooxygenase-2-dependent prostaglandin formation via a protein kinase C mitogen-activated protein kinase-dependent pathway

      JOURNAL OF BIOLOGICAL CHEMISTRY
    62. Mizushina, Y; Takahashi, N; Ogawa, A; Tsurugaya, K; Koshino, H; Takemura, M; Yoshida, S; Matsukage, A; Sugawara, F; Sakaguchi, K
      The cyanogenic glucoside, prunasin (D-mandelonitrile-beta-D-glucoside), isa novel inhibitor of DNA polymerase beta

      JOURNAL OF BIOCHEMISTRY
    63. Ramsewak, RS; Nair, MG; Strasburg, GM; DeWitt, DL; Nitiss, JL
      Biologically active carbazole alkaloids from Murraya koenigii

      JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
    64. Tegeder, I; Lotsch, J; Krebs, S; Muth-Selbach, U; Brune, K; Geisslinger, G
      Comparison of inhibitory effects of meloxicam and diclofenac on human thromboxane biosynthesis after single doses and at steady state

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    65. Ehrich, EW; Dallob, A; De Lepeleire, I; Van Hecken, A; Riendeau, D; Yuan, WY; Porras, A; Wittreich, J; Seibold, JR; De Schepper, P; Mehlisch, DR; Gertz, BJ
      Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    66. Giuliano, F; Warner, TD
      Ex vivo assay to determine the cyclooxygenase selectivity of non-steroidalanti-inflammatory drugs

      BRITISH JOURNAL OF PHARMACOLOGY
    67. KANEKI H; YOKOZAWA J; FUJIEDA M; MIZUOCHI S; ISHIKAWA C; IDE H
      PHORBOL ESTER-INDUCED PRODUCTION OF PROSTAGLANDIN E-2 FROM PHOSPHATIDYLCHOLINE THROUGH THE ACTIVATION OF PHOSPHOLIPASE-D IN UMR-106 CELLS

      Bone (New York, N.Y.)
    68. PAIRET M
      INHIBITION OF CYCLOOXYGENASE-1 AND CYCLOOXYGENASE-2 - ANALYSIS OF IN-VITRO TEST SYSTEMS AND THEIR CLINICAL RELEVANCE

      Journal of clinical rheumatology
    69. LORA M; DENAULT JB; LEDUC R; DEBRUMFERNANDES AJ
      SYSTEMATIC PHARMACOLOGICAL APPROACH TO THE CHARACTERIZATION OF NSAIDS

      Prostaglandins, leukotrienes and essential fatty acids
    70. SMITH TJ
      CYCLOOXYGENASES AS THE PRINCIPAL TARGETS FOR THE ACTIONS OF NSAIDS

      Rheumatic diseases clinics of North America
    71. WANG JL; CHENG HF; ZHANG MZ; MCKANNA JA; HARRIS RC
      SELECTIVE INCREASE OF CYCLOOXYGENASE-2 EXPRESSION IN A MODEL OF RENALABLATION

      American journal of physiology. Renal, fluid and electrolyte physiology
    72. GESCHER A
      ANALOGS OF STAUROSPORINE - POTENTIAL ANTICANCER DRUGS

      General pharmacology
    73. VANE JR; BOTTING RM
      MECHANISM OF ACTION OF ANTIINFLAMMATORY DRUGS

      International journal on tissue reactions
    74. HEFFELFINGER SC; MILLER MA; GEAR R; DEVOE G
      STAUROSPORINE-INDUCED VERSUS SPONTANEOUS SQUAMOUS METAPLASIA IN PREMENOPAUSAL AND POSTMENOPAUSAL BREAST-TISSUE

      Journal of cellular physiology
    75. LU ZX; HASMEDA M; MAHABUSARAKAM W; TERNAI B; TERNAI PC; POLYA GM
      INHIBITION OF EUKARYOTE PROTEIN-KINASES AND OF A CYCLIC NUCLEOTIDE-BINDING PHOSPHATASE BY PRENYLATED XANTHONES

      Chemico-biological interactions
    76. BURITOVA J; BESSON JM
      PERIPHERAL AND OR CENTRAL EFFECTS OF RACEMIC-FLURBIPROFEN, S(+)-FLURBIPROFEN AND R(-)-FLURBIPROFEN ON INFLAMMATORY NOCICEPTIVE PROCESSES - A C-FOS PROTEIN STUDY IN THE RAT SPINAL-CORD/

      British Journal of Pharmacology
    77. BARNES CJ; CAMERON IL; HARDMAN WE; LEE M
      NONSTEROIDAL ANTIINFLAMMATORY DRUG EFFECT ON CRYPT CELL-PROLIFERATIONAND APOPTOSIS DURING INITIATION OF RAT COLON CARCINOGENESIS

      British Journal of Cancer
    78. RICKETTS AP; LUNDY KM; SEIBEL SB
      EVALUATION OF SELECTIVE-INHIBITION OF CANINE CYCLOOXYGENASE-1 AND CYCLOOXYGENASE-2 BY CARPROFEN AND OTHER NONSTEROIDAL ANTIINFLAMMATORY DRUGS

      American journal of veterinary research
    79. CRYER B; FELDMAN M
      CYCLOOXYGENASE-1 AND CYCLOOXYGENASE-2 SELECTIVITY OF WIDELY USED NONSTEROIDAL ANTIINFLAMMATORY DRUGS

      The American journal of medicine
    80. BERG J; CHRISTOPH T; WIDERNA M; BODENTEICH A
      ISOENZYME-SPECIFIC CYCLOOXYGENASE INHIBITORS - A WHOLE-CELL ASSAY SYSTEM USING THE HUMAN ERYTHROLEUKEMIC CELL-LINE HEL AND THE HUMAN MONOCYTIC CELL-LINE MONO-MAC-6

      Journal of pharmacological and toxicological methods
    81. FUTAKI N; TAKAHASHI S; KITAGAWA T; YAMAKAWA Y; TANAKA M; HIGUCHI S
      SELECTIVE-INHIBITION OF CYCLOOXYGENASE-2 BY NS-398 IN ENDOTOXIN-SHOCKRATS IN-VIVO

      Inflammation research
    82. FAMAEY JP
      IN-VITRO AND IN-VIVO PHARMACOLOGICAL EVIDENCE OF SELECTIVE CYCLOOXYGENASE-2 INHIBITION BY NIMESULIDE - AN OVERVIEW

      Inflammation research
    83. LORA M; MORISSET S; MENARD HA; LEDUC R; DEBRUMFERNANDES AJ
      EXPRESSION OF RECOMBINANT HUMAN CYCLOOXYGENASE ISOENZYMES IN TRANSFECTED COS-7 CELLS IN-VITRO AND INHIBITION BY TENOXICAM, INDOMETHACIN ANDASPIRIN

      Prostaglandins, leukotrienes and essential fatty acids
    84. LEVY GN
      PROSTAGLANDIN-H SYNTHASES, NONSTEROIDAL ANTIINFLAMMATORY DRUGS, AND COLON-CANCER

      The FASEB journal
    85. BEVERELLI F; BEA ML; PUYBASSET L; GIUDICELLI JF; BERDEAUX A
      CHRONIC INHIBITION OF NO SYNTHASE ENHANCES THE PRODUCTION OF PROSTACYCLIN IN CORONARY-ARTERIES THROUGH UP-REGULATION OF THE CYCLOOXYGENASE TYPE-1 ISOFORM

      Fundamental and clinical pharmacology
    86. MIKAMI Y; MIZUNO M; MAGA T; KIHARA Y; YOSHINAGA F; TANAKA S; YUNOKI N; KAWAHARA T; OKADA H; TSUJI T
      GERANYLGERANYLACETONE AND CETRAXATE HYDROCHLORIDE INCREASE UDP-GALACTOSYLTRANSFERASE ACTIVITY IN RAT GASTRIC-MUCOSA

      Acta medica Okayama
    87. DEBRUMFERNANDES AJ
      NEW PERSPECTIVES FOR NONSTEROIDAL ANTIINFLAMMATORY THERAPY

      Journal of rheumatology
    88. DVORNIK DM
      TISSUE-SELECTIVE INHIBITION OF PROSTAGLANDIN BIOSYNTHESIS BY ETODOLAC

      Journal of rheumatology
    89. PEREIRA FJ; DRESCHER P; RAUCH D; MADSEN PO; WILL JA
      COMPARATIVE REGULATION OF ALPHA(1)-ADRENERGIC RECEPTOR-MEDIATED CONTRACTION IN UROGENITALLY DERIVED SMOOTH-MUSCLE - EFFECT OF EPIDERMAL GROWTH-FACTOR

      Urological research
    90. BARNES CJ; HARDMAN WE; CAMERON IL; LEE M
      ASPIRIN, BUT NOT SODIUM-SALICYLATE, INDOMETHACIN, OR NABUMETONE, REVERSIBLY SUPPRESSES 1,2-DIMETHYLHYDRAZINE-INDUCED COLONIC ABERRANT CRYPTFOCI IN RATS

      Digestive diseases and sciences
    91. WEST RE; WILLIAMS SM; SHE HS; CARRUTHERS NI; EGAN RW; BILLAH MM
      TOMOXIPROLE SELECTIVELY INHIBITS CYCLOOXYGENASE-2

      Prostaglandins
    92. VANE JR; BOTTING RM
      MECHANISM OF ACTION OF ASPIRIN-LIKE DRUGS

      Seminars in arthritis and rheumatism
    93. TSUJII M; KAWANO S; DUBOIS RN
      CYCLOOXYGENASE-2 EXPRESSION IN HUMAN COLON-CANCER CELLS INCREASES METASTATIC POTENTIAL

      Proceedings of the National Academy of Sciences of the United Statesof America
    94. KANAMORI Y; NIWA M; KOHNO K; ALESSA LY; MATSUNO H; KOZAWA O; UEMATSU T
      MIGRATION OF NEUTROPHILS FROM BLOOD TO TISSUE - ALTERATION OF MODULATORY EFFECTS OF PROSTANOID ON SUPEROXIDE GENERATION IN RABBITS AND HUMANS

      Life sciences
    95. CURNOCK AP; ROBSON PA; YEA CM; MOSS D; GADHER S; THOMSON TA; WESTWOOD R; RUUTH E; WILLIAMSON RA
      POTENCIES OF LEFLUNOMIDE AND HR325 AS INHIBITORS OF PROSTAGLANDIN-ENDOPEROXIDE-H SYNTHASE-1 AND SYNTHASE-2 - COMPARISON WITH NONSTEROIDAL ANTIINFLAMMATORY DRUGS

      The Journal of pharmacology and experimental therapeutics
    96. LAZER ES; MIAO CK; CYWIN CL; SORCEK R; WONG HC; MENG ZX; POTOCKI I; HOERMANN M; SNOW RJ; TSCHANTZ MA; KELLY TA; MCNEILL DW; COUTTS SJ; CHURCHILL L; GRAHAM AG; DAVID E; GROB PM; ENGEL W; MEIER H; TRUMMLITZ G
      EFFECT OF STRUCTURAL MODIFICATION OF ENOL-CARBOXAMIDE-TYPE NONSTEROIDAL ANTIINFLAMMATORY DRUGS ON COX-2 COX-1 SELECTIVITY/

      Journal of medicinal chemistry
    97. SHENG HM; SHAO JY; KIRKLAND SC; ISAKSON P; COFFEY RJ; MORROW J; BEAUCHAMP RD; DUBOIS RN
      INHIBITION OF HUMAN COLON-CANCER CELL-GROWTH BY SELECTIVE-INHIBITION OF CYCLOOXYGENASE-2

      The Journal of clinical investigation
    98. NEUPERT W; BRUGGER R; EUCHENHOFER C; BRUNE K; GEISSLINGER G
      EFFECTS OF IBUPROFEN ENANTIOMERS AND ITS COENZYME-A THIOESTERS ON HUMAN PROSTAGLANDIN ENDOPEROXIDE SYNTHASES

      British Journal of Pharmacology
    99. SIMON LS; STRAND V
      CLINICAL-RESPONSE TO NONSTEROIDAL ANTIINFLAMMATORY DRUGS

      Arthritis and rheumatism
    100. DRAPER AJ; MADAN A; PARKINSON A
      INHIBITION OF COUMARIN 7-HYDROXYLASE ACTIVITY IN HUMAN LIVER-MICROSOMES

      Archives of biochemistry and biophysics


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/06/20 alle ore 06:15:22